Oui, les anticoagulants réduisent le risque de thromboses chez les patients atteints.
AnticoagulantsThromboseEfficacité du traitement
#3
Le traitement est-il à vie ?
Pas toujours, mais de nombreux patients nécessitent un traitement à long terme.
Traitement à long termeSyndrome des anticorps antiphospholipidesAnticoagulants
#4
Y a-t-il des effets secondaires aux traitements ?
Oui, les anticoagulants peuvent causer des saignements et d'autres effets indésirables.
Effets secondairesAnticoagulantsSaignements
#5
Les femmes enceintes peuvent-elles être traitées ?
Oui, des anticoagulants comme l'héparine sont souvent utilisés pendant la grossesse.
GrossesseHéparineAnticoagulants
Complications
5
#1
Quelles sont les complications possibles du syndrome ?
Les complications incluent des thromboses veineuses profondes, des AVC et des fausses couches.
ThrombosesAVCFausses couches
#2
Le syndrome peut-il causer des problèmes cardiaques ?
Oui, il peut augmenter le risque de maladies cardiovasculaires et d'infarctus.
Maladies cardiovasculairesInfarctusSyndrome des anticorps antiphospholipides
#3
Y a-t-il des risques pour la santé mentale ?
Oui, des troubles anxieux et dépressifs peuvent survenir chez certains patients.
Santé mentaleTroubles anxieuxDépression
#4
Les complications sont-elles réversibles ?
Certaines complications peuvent être gérées, mais d'autres peuvent avoir des effets durables.
ComplicationsGestionEffets durables
#5
Le syndrome augmente-t-il le risque de cancer ?
Des études suggèrent un lien possible, mais des recherches supplémentaires sont nécessaires.
CancerSyndrome des anticorps antiphospholipidesRecherche
Facteurs de risque
5
#1
Quels sont les facteurs de risque du syndrome ?
Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections.
Facteurs de risqueMaladies auto-immunesInfections
#2
Le sexe influence-t-il le risque ?
Oui, le syndrome est plus fréquent chez les femmes, surtout entre 20 et 40 ans.
SexeFemmesSyndrome des anticorps antiphospholipides
#3
Les antécédents de thromboses augmentent-ils le risque ?
Oui, avoir des antécédents de thromboses augmente significativement le risque de syndrome.
Antécédents médicauxThromboseSyndrome des anticorps antiphospholipides
#4
Les infections virales sont-elles un facteur de risque ?
Certaines infections virales, comme le VIH, peuvent augmenter le risque de développer le syndrome.
Infections viralesVIHFacteurs de risque
#5
Le tabagisme influence-t-il le risque ?
Oui, le tabagisme est associé à un risque accru de thromboses et de complications.
TabagismeThromboseFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome des anticorps antiphospholipides : Questions médicales les plus fréquentes",
"headline": "Syndrome des anticorps antiphospholipides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome des anticorps antiphospholipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-12",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes",
"url": "https://questionsmedicales.fr/mesh/D001327",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes",
"code": {
"@type": "MedicalCode",
"code": "D001327",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides",
"alternateName": "Antiphospholipid Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D016736",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Doruk Erkan",
"url": "https://questionsmedicales.fr/author/Doruk%20Erkan",
"affiliation": {
"@type": "Organization",
"name": "Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, and Weill Cornell Medicine, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "Hannah Cohen",
"url": "https://questionsmedicales.fr/author/Hannah%20Cohen",
"affiliation": {
"@type": "Organization",
"name": "Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK."
}
},
{
"@type": "Person",
"name": "Imad Uthman",
"url": "https://questionsmedicales.fr/author/Imad%20Uthman",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon."
}
},
{
"@type": "Person",
"name": "Katrien M J Devreese",
"url": "https://questionsmedicales.fr/author/Katrien%20M%20J%20Devreese",
"affiliation": {
"@type": "Organization",
"name": "Coagulation Laboratory, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium."
}
},
{
"@type": "Person",
"name": "Yu Zuo",
"url": "https://questionsmedicales.fr/author/Yu%20Zuo",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Modeling Low Muscle Mass Screening in Hemodialysis Patients.",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36273447",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000526866"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fat-Free Mass Index as a Surrogate Marker of Appendicular Skeletal Muscle Mass Index for Low Muscle Mass Screening in Sarcopenia.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36179769",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jamda.2022.08.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "The dilemma of recalling well-circumscribed masses in a screening population: A narrative literature review and exploration of Dutch screening practice.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37169601",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.breast.2023.05.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-effectiveness analysis of newborn screening by tandem mass spectrometry in Shenzhen, China: value and affordability of new screening technology.",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35971172",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-022-08394-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The efficacy of mass screening for chronic obstructive pulmonary disease using screening questionnaires in a medical health check-up population.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36057534",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.resinv.2022.07.005"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndrome des anticorps antiphospholipides",
"item": "https://questionsmedicales.fr/mesh/D016736"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome des anticorps antiphospholipides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome des anticorps antiphospholipides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome des anticorps antiphospholipides",
"description": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères sont utilisés pour le diagnostic ?\nLe diagnostic nécessite-t-il des symptômes cliniques ?\nPeut-on avoir le syndrome sans symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Mass+Screening#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les symptômes courants du syndrome ?\nLe syndrome peut-il causer des douleurs ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLe syndrome affecte-t-il la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Mass+Screening#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome des anticorps antiphospholipides",
"description": "Comment prévenir les complications du syndrome ?\nY a-t-il des changements de mode de vie recommandés ?\nLes femmes enceintes doivent-elles être surveillées ?\nLes vaccinations sont-elles importantes ?\nLe stress a-t-il un impact sur le syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Mass+Screening#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome des anticorps antiphospholipides",
"description": "Quels traitements sont disponibles pour le syndrome ?\nLes anticoagulants sont-ils efficaces ?\nLe traitement est-il à vie ?\nY a-t-il des effets secondaires aux traitements ?\nLes femmes enceintes peuvent-elles être traitées ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Mass+Screening#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome des anticorps antiphospholipides",
"description": "Quelles sont les complications possibles du syndrome ?\nLe syndrome peut-il causer des problèmes cardiaques ?\nY a-t-il des risques pour la santé mentale ?\nLes complications sont-elles réversibles ?\nLe syndrome augmente-t-il le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Mass+Screening#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les facteurs de risque du syndrome ?\nLe sexe influence-t-il le risque ?\nLes antécédents de thromboses augmentent-ils le risque ?\nLes infections virales sont-elles un facteur de risque ?\nLe tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Mass+Screening#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps antiphospholipides."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le lupus anticoagulant, les anticorps anti-cardiolipine et anti-bêta-2-glycoprotéine I."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des antécédents de thromboses et la présence d'anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Le diagnostic nécessite-t-il des symptômes cliniques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de thromboses ou de complications obstétricales sont souvent requis."
}
},
{
"@type": "Question",
"name": "Peut-on avoir le syndrome sans symptômes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent avoir des anticorps sans présenter de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des thromboses, des fausses couches et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison de thromboses dans les vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des maux de tête, des AVC ou des troubles cognitifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Le syndrome affecte-t-il la grossesse ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des complications comme des fausses couches ou des prééclampsies."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications du syndrome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la prise régulière d'anticoagulants et le suivi médical."
}
},
{
"@type": "Question",
"name": "Y a-t-il des changements de mode de vie recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé, faire de l'exercice et éviter le tabac sont conseillés."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance étroite est essentielle pour prévenir les complications obstétricales."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent le syndrome."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le syndrome ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, donc des techniques de gestion du stress sont utiles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des anticoagulants et des médicaments immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Les anticoagulants sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants réduisent le risque de thromboses chez les patients atteints."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à vie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais de nombreux patients nécessitent un traitement à long terme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants peuvent causer des saignements et d'autres effets indésirables."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles être traitées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticoagulants comme l'héparine sont souvent utilisés pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du syndrome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des thromboses veineuses profondes, des AVC et des fausses couches."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut augmenter le risque de maladies cardiovasculaires et d'infarctus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles anxieux et dépressifs peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent avoir des effets durables."
}
},
{
"@type": "Question",
"name": "Le syndrome augmente-t-il le risque de cancer ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien possible, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du syndrome ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le syndrome est plus fréquent chez les femmes, surtout entre 20 et 40 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents de thromboses augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de thromboses augmente significativement le risque de syndrome."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de développer le syndrome."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de thromboses et de complications."
}
}
]
}
]
}
Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano-Istituto di Ricovero e Cura a Carattere Scientifico, Milano, Italy.
Publications dans "Syndrome des anticorps antiphospholipides" :
Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, Spain.
Publications dans "Syndrome des anticorps antiphospholipides" :
Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Aosta Valley Network for Rare Diseases, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, University of Turin, Italy; Nephrology and Dialysis, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Italy.
Publications dans "Syndrome des anticorps antiphospholipides" :
Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Aosta Valley Network for Rare Diseases, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, University of Turin, Italy; Nephrology and Dialysis, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Italy. Electronic address: savino.sciascia@unito.it.
Publications dans "Syndrome des anticorps antiphospholipides" :
Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Publications dans "Syndrome des anticorps antiphospholipides" :
Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Publications dans "Syndrome des anticorps antiphospholipides" :
Computed tomography (CT) can accurately measure muscle mass, which is necessary for diagnosing sarcopenia, even in dialysis patients. However, CT-based screening for such patients is challenging, espe...
Hemodialysis patients (n = 619) who had undergone abdominal CT screening were divided into the development (n = 441) and validation (n = 178) groups. PMI was manually measured using abdominal CT image...
Of all subjects, 226 (37%) were diagnosed with low muscle mass using PMI. A predictive model for low muscle mass was calculated using ten variables: each grip strength, sex, height, dry weight, primar...
Our results facilitate skeletal muscle screening in hemodialysis patients, assisting in sarcopenia prophylaxis and intervention decisions....
We aimed to examine the relationship between the fat-free mass index (FFMI; FFM/height...
Cross-sectional study....
This study included 1313 adults (women, 33.6%) aged 40-87 years (mean age, 55 ± 10 years) from the WASEDA'S Health Study....
Body composition was measured using multifrequency BIA and DXA. Low muscle mass was defined according to the criteria of the Asian Working Group for Sarcopenia 2019....
BIA-measured FFMI showed strong positive correlations with both BIA- (r = 0.96) and DXA-measured (r = 0.95) ASMIs. Similarly, in the subgroup analysis according to age and obesity, the FFMI was correl...
The FFMI showed a strong positive correlation with BIA- and DXA-measured ASMIs, regardless of age and obesity. The FFMI could be a useful simple surrogate marker of the ASMI for low muscle mass screen...
In Dutch breast cancer screening, solitary, new or growing well-circumscribed masses should be recalled for further assessment. This results in cancers detected but also in false positive recalls, esp...
A systematic literature search was performed using PubMed. In addition, follow-up data were retrieved on all 8860 recalled women in a Dutch screening region from 2014 to 2019....
Based on 15 articles identified in the literature search, we found that probably benign well-circumscribed masses that were kept under surveillance had a positive predictive value (PPV) of 0-2%. New o...
To recognize malignancies presenting as well-circumscribed masses, identifying solitary, new or growing lesions is key. This information is missing at initial screening since prior examinations are no...
Newborn screening (NBS) can prevent inborn errors of metabolism (IEMs), which may cause long-term disability and even death in newborns. However, in China, tandem mass spectrometry (MS/MS) screening h...
A Markov model was built to estimate the cost and quality-adjusted life-years (QALYs) of different screening programs. We compared PKU screening using traditional immunofluorescence (IF) with the othe...
The incremental cost-effectiveness ratio (ICER) of detecting all 12 IEMs in the national program is 277,823 RMB per QALY, below three times per capita GDP in Shenzhen. MS/MS screening in Shenzhen can ...
We conclude that the newborn screening using MS/MS in Shenzhen is cost-effective, and the budget affordable for the Shenzhen government. Two concepts for selecting the IEMs to be detected are also pre...
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease, highlighting the need for efficient screening strategies to identify patients with COPD. However, there is little e...
In this cross-sectional study, we originally investigated the efficacy of mass screening for COPD among community residents in the aforementioned region using two COPD screening questionnaires....
From July 2018 through January 2019, 688 participants were enrolled. COPD was diagnosed using the Global Initiative for the Chronic Obstructive Lung Disease criteria. Twenty-one patients were newly di...
Mass screening for COPD using screening questionnaires, particularly the COPD-PS questionnaire, might be useful to identify the early stages of COPD in a medical health check-up population....
Although the study design for identifying specific disease associations using a health insurance database has been well-established, few studies explore unknown comorbidities. We conducted a series of...
Gastric cancer is an inflammation-related cancer triggered by Helicobacter pylori infection. Understanding of the natural disease course has prompted the hypothesis that gastric cancer can be prevente...
The early detection of symptoms and rapid testing are the basis of an efficient screening strategy to control COVID-19 transmission. The olfactory dysfunction is one of the most prevalent symptom and ...
The main goal of this study was to examine the relationship between exposure to mass media health campaign massages and the uptake of non-communicable diseases (NCDs) screening services in Ghana and w...
Updated data on the seroprevalences of hepatitis B and C viruses (HBV, HCV) are required to enable the adaptation of control strategies. In this study, we aimed to: (i) estimate the seroprevalences of...
From October 2020 to October 2022, a mass screening campaign was conducted in 10 cities across Burkina Faso. Individuals of all ages and genders who consented to participate were screened for viral ma...
A total of 15,650 participants were enrolled in the study. Of these, 51.4% were women and the age range was from 1 to 97 years. All participants were screened for HBsAg and 7,507 were also screened fo...
The prevalence of HBV and HCV infections remains high in Burkina Faso. Prevention strategies, including initial mass screening with rapid diagnostic tests and vaccination, need to be intensified....
